Meg Wood

Director/Board Member at

Aronora, Inc.

Health Technology

Finance

Consumer Services

Profile

Meg Wood is a venture capital business development executive with experience creating emerging growth strategies for portfolio investment.
As the Managing Director of NYBC Ventures, Meg oversees deal execution and management.
Board Observer for NYBC Ventures portfolio companies Catena Biosciences and KaloCyte.
Previously, Meg built and managed a $50 million fund for scientific research and innovation for a rare disease as the Vice President of Business Development at CD Ventures.
She has deep experience deploying investment capital for mission-oriented fund structures.
Prior to her role at CD Ventures, she held positions at MPM Capital, Tufts Medical Center and Boston Medical Center.
She received Master’s degrees in social work and public health from Boston University and her BA from the College of Charleston.

Meg Wood active positions

Companies	Position	Start
Nybc Ventures Nybc Ventures Investment ManagersFinance NYBC Ventures invests in companies located in the United States. The firm targets companies operating in the fields of blood & cellular therapies and related technologies. It provides financing for early stage capital requirements.	Private Equity Investor	01/04/2022
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Private Equity Investor	01/09/2021
Aronora, Inc. Aronora, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of biologic drugs	Director/Board Member	01/07/2023
Rarebase, PBC Rarebase, PBC BiotechnologyHealth Technology Provides drug discovery services	Consultant / Advisor	01/08/2021
Thymmune Therapeutics Thymmune Therapeutics BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company that develops regenerative thymic cell therapies for the treatment of posttransplant organ tolerance, immunodeficiencies and autoimmune diseases	Director/Board Member	01/03/2023
KaloCyte, Inc. KaloCyte, Inc. BiotechnologyHealth Technology Develops red blood cell substitutes used for trauma care related treatments	Director/Board Member	01/05/2022

All active positions of Meg Wood

Former positions of Meg Wood

Companies	Position	End
CureDuchenne Ventures LLC CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements.	Private Equity Investor	01/08/2021
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Private Equity Investor	01/06/2016
Catena Biosciences, Inc. Catena Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics through protein conjugation technologies	Director/Board Member	-

See the detail of Meg Wood's experience

Training of Meg Wood

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Meg Wood's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Health Services
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Finance
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
College of Charleston College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CureDuchenne Ventures LLC CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements.	Finance
KaloCyte, Inc. KaloCyte, Inc. BiotechnologyHealth Technology Develops red blood cell substitutes used for trauma care related treatments	Health Technology
Aronora, Inc. Aronora, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of biologic drugs	Health Technology
Rarebase, PBC Rarebase, PBC BiotechnologyHealth Technology Provides drug discovery services	Health Technology
Catena Biosciences, Inc. Catena Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics through protein conjugation technologies	Health Technology
Thymmune Therapeutics Thymmune Therapeutics BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company that develops regenerative thymic cell therapies for the treatment of posttransplant organ tolerance, immunodeficiencies and autoimmune diseases	Health Technology
Nybc Ventures Nybc Ventures Investment ManagersFinance NYBC Ventures invests in companies located in the United States. The firm targets companies operating in the fields of blood & cellular therapies and related technologies. It provides financing for early stage capital requirements.	Finance

See company connections